Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Novartis to acquire Avidity Biosciences

Lucid Diligence Brief: Novartis to acquire Avidity Biosciences Professional…


Cell_Gene_Therapy

Cell and Gene Therapy Weekly News - October 2nd 2025

Gene & Cell Therapy Update: eXmoor × Siam Bioscience Partnership, FDA Fast…


Rare Disease news

Rare Diseases Weekly News - September 18th 2025

🧬 This Week in Rare Diseases: Positive DMD Results, FDA Approves Selumetinib…


Cell_Gene_Therapy

Cell and Gene Therapy Weekly News - September 4th 2025

🧬 This Week in Gene & Cell Therapy: EU CAR-T Rollout, RMAT for Dravet, DMD…


Rare Disease news

Rare Diseases Weekly News - August 7th 2025

🧬 This Week in Rare Diseases: Europe’s R&D at Risk, AI Drug Discovery, New…


Rare Disease news

Rare Diseases Weekly News - July 31st 2025

🧬 This Week in Rare Diseases: FDA Leadership, Gene Therapy Safety, New Drug…


Rare Disease news

Rare Diseases Weekly News - July 3rd 2025

🧬 This Week in Rare Diseases: First MAS Approval, AI-Powered Diagnostics,…


Neuroscience

Neuroscience Weekly News - July 2nd 2025

🧠 This Week in Neuroscience: FDA Approvals, ALS Breakthroughs, Gene Therapies…


Rare Disease news

Rare Diseases Weekly News - June 26th 2025

🧬 This Week in Rare Diseases: Genome Testing, First Approvals, Global…


Neuroscience

Neuroscience Weekly News - June 25th 2025

🧠 This Week in Neuroscience: Migraine Breakthroughs, MS Innovations, DMD Heart…


Cell_Gene_Therapy

Cell and Gene Therapy Weekly News - May 8th 2025

This Week in Gene & Cell Therapy: Gene Therapy Milestones, Strategic…


Privacy Preference Center